Search by Drug Name or NDC
NDC 39822-1077-01 Voriconazole 10 mg/mL Details
Voriconazole 10 mg/mL
Voriconazole is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XGen Pharmaceuticals DJB, Inc.. The primary component is VORICONAZOLE.
Product Information
| NDC | 39822-1077 |
|---|---|
| Product ID | 39822-1077_0bb396c9-ff0e-ae6b-e063-6294a90a9d5d |
| Associated GPIs | 11407080002120 |
| GCN Sequence Number | 050444 |
| GCN Sequence Number Description | voriconazole VIAL 200 MG INTRAVEN |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 17499 |
| HICL Sequence Number | 023720 |
| HICL Sequence Number Description | VORICONAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Voriconazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | VORICONAZOLE |
| Labeler Name | XGen Pharmaceuticals DJB, Inc. |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208562 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 39822-1077-01 (39822107701)
| NDC Package Code | 39822-1077-1 |
|---|---|
| Billing NDC | 39822107701 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (39822-1077-1) / 20 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2017-04-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |